Roche Introduces Alzheimer's Blood Test Developed for Individuals Over 55
Roche announced its new blood test developed to detect signs of Alzheimer's accompanied by clinical symptoms in individuals over the age of 55.
At a meeting held by Roche in Basel, Switzerland, a new blood test was introduced that helps detect signs associated with Alzheimer's in individuals aged 55 and over before forgetfulness begins.
Purpose and Use of the Blood Test
Administered through a few tubes of blood, the test helps determine signs associated with Alzheimer's in individuals aged 55 and over who exhibit symptoms or complaints of cognitive decline.
Its Place in the Diagnostic Process
This test does not directly diagnose Alzheimer's; rather, it is used as part of the diagnostic process by being evaluated together with the patient's clinical information and other medical findings.
Human Biology and Model Systems
Dr. Azad Bonni, Global Head and Director of the Roche Institute for Human Biology, shared the importance of research aimed at understanding human disease biology during the meeting in Basel, Switzerland.
Organoids in Laboratory Environment
Organoids developed from stem cells by the IHB are designed as small models that recreate specific characteristics of human tissues and organs in a laboratory setting.
Drug Development and Animal Testing
It is stated that the developed human model systems have the potential to reduce the reliance on animal testing in the early stages of the drug development process.
Goal in Alzheimer's Research
Due to the complexity of human brain biology, the primary goal in Alzheimer's is not necessarily finding a new drug, but understanding the biology of the disease at a much earlier stage.